文献速递中医妇科中药与中成药合理使用

寿胎丸调控肾虚流产小鼠母胎界面糖酵解失衡

Shoutai Wan regulates glycolysis imbalance at the maternal-fetal interface in threatened abortion mice.
PubMed 文献 · J Ethnopharmacol · 2023-04-15

该研究用气相色谱-质谱分析寿胎丸成分,在氢化可的松联合米非司酮诱导的肾虚先兆流产小鼠模型中观察不同剂量寿胎丸对母胎界面糖酵解的影响。结果显示寿胎丸高剂量组与地屈孕酮组均降低胚胎丢失率,并上调HIF-1α及糖酵解相关酶与乳酸水平。

要点

  • 寿胎丸高剂量可降低肾虚先兆流产模型小鼠的胚胎丢失率。
  • 寿胎丸可改善母胎界面形态并上调HIF-1α表达。
  • 寿胎丸上调HK、PKM、LDH活性及乳酸浓度和糖酵解相关蛋白表达。

核心结论

  • 寿胎丸可通过调节母胎界面糖酵解平衡降低肾虚先兆流产模型小鼠的妊娠丢失率。

研究设计与样本

  • 研究使用氢化可的松和米非司酮诱导的妊娠小鼠先兆流产模型,并以气相色谱-质谱分析寿胎丸成分。
  • 寿胎丸高、中、低剂量分别按3 mg/ml、1.5 mg/ml、0.75 mg/ml于妊娠第1-9天上午给药,下午给予2 mg/ml氢化可的松,第10天给予0.4 mg/kg米非司酮一次。
  • 地屈孕酮组以0.1 mg/ml地屈孕酮替代寿胎丸,模型组以等量纯水替代,对照组以纯水替代寿胎丸、氢化可的松和米非司酮。

主要发现

  • 寿胎丸高剂量组和地屈孕酮组的胚胎丢失率低于模型组。
  • HE染色显示寿胎丸高剂量组和地屈孕酮组母胎界面形态改善。
  • 免疫组化、qRT-PCR和Western blot结果显示寿胎丸高剂量组和地屈孕酮组母胎界面HIF-1α表达高于模型组。
  • 寿胎丸高剂量组和地屈孕酮组HK、PKM、LDH活性及乳酸浓度高于模型组。
  • 寿胎丸高剂量组和地屈孕酮组HK2、PKM2、LDHA、MCT4和GPR81的蛋白与mRNA水平高于模型组。

临床怎么用

  • 寿胎丸补肾安胎作用可能部分通过调控母胎界面糖酵解实现,为临床用于肾虚型先兆流产提供实验依据。

局限性

  • 研究为动物实验,寿胎丸的临床疗效与安全性尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Threatened abortion is a common disease among women of childbearing age. Its high incidence rate and unclear etiology, seriously threaten women's physical and mental health. Shoutai Wan (STW) is a traditional Chinese medicine decoction for treating abortion. It has a long history of treating threatened abortion by tonifying the kidney and calming the fetus. However, the mechanism of STW remains unclear. AIM OF STUDY: To study the mechanism and potential benefit of STW in pregnant mice with hydrocortisone and mifepristone-induced threatened abortion. MATERIALS AND METHODS: The STW compounds were identified using gas chromatography-mass spectrometry analysis. STW-H, STW-M, or STW-L was separately given 3 mg/ml, 1.5 mg/ml and 0.75 mg/ml STW in the morning, and 2 mg/ml hydrocortisone in the afternoon from gestation day (D) 1-9 and once with 0.4 mg/kg mifepristone on D10. Didroxyprogesterone (0.1 mg/ml) and equal dose pure water were used to replace STW in didroxyprogesterone (DYD) group and model group respectively. The control group used pure water to replace STW, hydrocortisone, and mifepristone. We performed morphological and histological analyses of the maternal-fetal interface on day 10. RESULTS: The embryo loss rate in the STW-H and DYD groups was lower than that in the model group. Hematoxylin and eosin (HE) staining suggested that the morphology of maternal-fetal interface was improved in the STW-H and DYD groups. Immunohistochemical (IHC), Quantitative Reverse Transcription Polymerase Chain Reactionstaining (qRT-PCR), and Western blot (WB) results indicated that HIF-1α expression in the maternal-fetal interface of the STW-H and DYD groups was higher than that in model group. The activities of HK, PKM, LDH and the concentration of lactic acid in the STW-H and DYD groups were higher than those in model group. Furthermore, the protein and mRNA levels of HK2, PKM2, LDHA, MCT4, and GPR81 were higher in the STW-H and DYD groups than those in the model group. CONCLUSIONS: STW can reduce the pregnancy loss rate by regulating the glycolysis balance at the maternal-fetal interface of kidney deficiency threatened abortion model mice.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang L, Wang S, Ma Y, et al. Shoutai Wan regulates glycolysis imbalance at the maternal-fetal interface in threatened abortion mice. J Ethnopharmacol. 2023. PMID: 37068718. doi:10.1016/j.jep.2023.116502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。